OBN awards.jpg

Image -

OBN awards.jpg

go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.jpg
Size:
1342 x 402, 138 KB
Download

Topics

Contacts

Georgina Horton

Georgina Horton

Press contact Head of Communications 01235 436225

Related content

Isansys wins Best Established Medtech Company Award

Isansys wins Best Established Medtech Company Award

Isansys Lifecare has won the title of Best Established Medtech Company at the prestigious 2021 OBN Awards.
The company, based in Oxfordshire, was recognised for the development of its Patient Status Engine (PSE), an advanced remote patient monitoring platform that collects and analyses patients’ vital signs and helps inform healthcare decisions.
The technology enables timely interventions th

Providing extraordinary new digital medical tools to transform patient data into valuable clinical insight

Isansys provides remote monitoring solutions which improve patient care, drive clinical performance, ensure economic value and enhance patient safety.

Headquartered in Oxfordshire, with subsidiaries in Germany, India and the US, Isansys is a privately limited company which was founded in 2010 by Keith Errey and Rebecca Weir.

Our business is to work with health professionals, insurance companies and healthcare organisations to provide more efficient patient monitoring against a backdrop of staff shortages and a rising number of patients and costs and limited budgets.

All our products and devices are fully certified and qualified medical devices.

Isansys

8C Park Square
OX14 4RR Oxford
United Kingdom

Privacy Policy
Privacy Policy for Contacts
Cookie Policy
Isansys Homepage
Enter your email address to follow Isansys

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Isansys.

Okay